Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESETT-I: Isunakinra + NAC/P in Triple-Negative Breast Cancer
NCT07698106Phase 2Recruiting
- Sponsor
- University Health Network
- Start
- Oct 2026
- Primary completion
- Aug 2034
- Countries
- 1
01
Overview
A Phase 2 trial of isunakinra in triple-negative breast cancer (TNBC), sponsored by University Health Network. Started Oct 2026; status: recruiting.
02
Drugs
isunakinra
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT07698106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07698106.